Literature DB >> 3069472

Disorders of the mitochondrial respiratory chain: clinical manifestations and diagnostic approach.

J M Trijbels1, R C Sengers, W Ruitenbeek, J C Fischer, J A Bakkeren, A J Janssen.   

Abstract

The clinical identification of patients with defects in the mitochondrial respiratory chain is almost impossible. We describe screening tests that should be performed in order to select those patients in whom a skeletal muscle biopsy should be carried out for more specific biochemical assays. The importance of performing in vivo function tests is stressed. The biochemical diagnosis in disorders of the respiratory chain is presented and the application of immunological methods discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3069472     DOI: 10.1007/bf00445910

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  A microspectrophotometric method for the determination of cytochrome oxidase.

Authors:  S J COOPERSTEIN; A LAZAROW
Journal:  J Biol Chem       Date:  1951-04       Impact factor: 5.157

2.  Microdetermination of (-)carnitine and carnitine acetyltransferase activity.

Authors:  R Parvin; S V Pande
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

Review 3.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

4.  Mitochondrial inheritance in a mitochondrially mediated disease.

Authors:  J Egger; J Wilson
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

5.  Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and DeToni-Fanconi-Debré syndrome.

Authors:  A Kitano; S Nishiyama; T Miike; S Hattori; Y Ohtani; I Matsuda
Journal:  Brain Dev       Date:  1986       Impact factor: 1.961

6.  Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle.

Authors:  N Bresolin; M Zeviani; E Bonilla; R H Miller; R W Leech; S Shanske; M Nakagawa; S DiMauro
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

7.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle.

Authors:  J C Fischer; W Ruitenbeek; J A Berden; J M Trijbels; J H Veerkamp; A M Stadhouders; R C Sengers; A J Janssen
Journal:  Clin Chim Acta       Date:  1985-11-29       Impact factor: 3.786

8.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

9.  Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain.

Authors:  N G Kennaway; N R Buist; V M Darley-Usmar; A Papadimitriou; S Dimauro; R I Kelley; R A Capaldi; N K Blank; A D'Agostino
Journal:  Pediatr Res       Date:  1984-10       Impact factor: 3.756

10.  A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency.

Authors:  R C Sengers; J C Fischer; J M Trijbels; W Ruitenbeek; A M Stadhouders; H J ter Laak; H H Jaspar
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

View more
  18 in total

1.  Evaluation of mitochondrial content and activity with nonyl-acridine orange and rhodamine 123: flow cytometric analysis and comparison with quantitative morphometry. Comparative analysis by flow cytometry and quantitative morphometry of mitochondrial content and activity.

Authors:  G Lizard; Y Chardonnet; M C Chignol; J Thivolet
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

2.  Prenatal diagnosis of systemic disorders of the respiratory chain in cultured amniocytes and chorionic villus fibroblasts by studying the formation of lactate and pyruvate from glucose.

Authors:  R J Wanders; F A Wijburg; J Ruiter; J M Trijbels; W Ruitenbeek; R C Sengers; J A Bakkeren; N Feller
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes.

Authors:  Catherine Deveaud; Bertrand Beauvoit; Bénédicte Salin; Jacques Schaeffer; Michel Rigoulet
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins.

Authors:  Marina A Schwab; Sven W Sauer; Jürgen G Okun; Leo G J Nijtmans; Richard J T Rodenburg; Lambert P van den Heuvel; Stefan Dröse; Ulrich Brandt; Georg F Hoffmann; Henk Ter Laak; Stefan Kölker; Jan A M Smeitink
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

5.  Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome c oxidase deficiency.

Authors:  W Lehnert; W Ruitenbeek
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Enzymological versus DNA investigations in mitochondrial (encephalo-) myopathies.

Authors:  D D de Vries; W Ruitenbeek; I J de Wijs; J M Trijbels; B A van Oost
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Mitochondrial creatine kinase activity in patients with disturbed energy generation in muscle mitochondria.

Authors:  J Smeitink; W Ruitenbeek; R Sengers; R Wevers; T van Lith; F Trijbels
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 8.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

9.  Exertional rhabdomyolysis in a patient with calcium adenosine triphosphatase deficiency.

Authors:  P J Poels; R A Wevers; J P Braakhekke; A A Benders; J H Veerkamp; E M Joosten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

10.  Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.

Authors:  G Kurlemann; I Paetzke; H Möller; H Masur; G Schuierer; J Weglage; H G Koch
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.